Sravan Emany
2021
In 2021, Sravan Emany earned a total compensation of $2.5M as Senior Vice President, Chief Financial Officer at Ironwood Pharmaceuticals.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Salary | $28,846 |
| Stock Awards | $2,300,100 |
| Other | $46 |
| Total | $2,528,992 |
Emany received $2.3M in stock awards, accounting for 91% of the total pay in 2021.
Emany also received $200K in bonus, $28.8K in salary and $46 in other compensation.
Rankings
In 2021, Sravan Emany's compensation ranked 5,102nd out of 12,415 executives tracked by ExecPay. In other words, Emany earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,102 out of 12,415 | 59th |
Division Manufacturing | 2,149 out of 5,505 | 61st |
Major group Chemicals And Allied Products | 924 out of 2,375 | 61st |
Industry group Drugs | 826 out of 2,096 | 61st |
Industry Pharmaceutical Preparations | 590 out of 1,546 | 62nd |
Source: SEC filing on April 21, 2022.
Emany's colleagues
We found six more compensation records of executives who worked with Sravan Emany at Ironwood Pharmaceuticals in 2021.
2021
Thomas McCourt
Ironwood Pharmaceuticals
Chief Executive Officer
2021
Jason Rickard
Ironwood Pharmaceuticals
Chief Operating Officer
2021
John Minardo
Ironwood Pharmaceuticals
Chief Legal Officer
2021
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
2021
Michael Shetzline
Ironwood Pharmaceuticals
Chief Medical Officer
2021
Mark Mallon
Ironwood Pharmaceuticals